Pre-sleep Protein Supplementation in British Army Recruits

Status Completed

Clinical Trial Summary

Dietary protein has been shown to be important to support physical training. For occupational demands such as military training, new recruits often fail to meet the recommended protein intake during basic training (BT), with negligible amounts consumed in the evening. As such, individuals undertaking BT may require higher intakes than the general population.This study assessed the influence of a daily bolus of protein prior to sleep on performance adaptations, body composition and recovery in British Army recruits.

Clinical Trial Description

Dietary protein is crucial for optimising physical training adaptations such as muscular strength and mass, which are key aims for athletic populations, including British Army recruits. New recruits fail to meet the recommended protein intake during basic training (BT), with negligible amounts consumed in the evening. This study aimed to assess the influence of a daily bolus of protein prior to sleep on performance adaptations, body composition and recovery in British Army recruits. The study will recruit a mixed cohort of >120 new recruits from the United Kingdom (UK) British Army who will be randomised into a dietary control (CON), carbohydrate placebo (PLA), moderate (20g) protein (MOD) or high (60g) protein (HIGH) supplementation group. Supplements will be isocaloric and consumed daily on weekday evenings between 2000 and 2100h for 10 weeks during BT, alongside standardised dietary intake and BT activities. Performance tests (mid-thigh pull, medicine ball throw, 2km run time, maximal push-up and maximal vertical jump) and body composition will be assessed at the start and end of BT under standardised conditions. Dietary intake, energy expenditure, salivary hormones, urinary nitrogen balance, perceived muscle soreness, rating of perceived exertion, mood and fatigue will be assessed at the start, middle and end of BT. The underlying aim of this study is to assess whether inclusion of nocturnal protein supplementation will influence performance adaptations, body composition changes or acute recovery in British Army recruits. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05998590
Study type	Interventional
Source	Anglia Ruskin University
Contact
Status	Completed
Phase	N/A
Start date	May 1, 2021
Completion date	May 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04085861` - Mental Health in Dancers; an Intervention Study	N/A
Active, not recruiting	`NCT02558920` - Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
Not yet recruiting	`NCT06026631` - Lipidomic Characterization in Non-metastatic Breast Cancer Women Undergoing Surgery: a Pilot Study.	N/A
Completed	`NCT03850990` - Effect of Gut-Cued Eating on BMI and Efficacy of Open-Label Placebo to Augment Weight Loss	N/A
Not yet recruiting	`NCT03601273` - Bariatric Embolization Trial for the Obese Nonsurgical	Phase 1
Completed	`NCT02899559` - Messages and Plans to Increase Gym Utilization	N/A
Active, not recruiting	`NCT02557022` - Meta Analysis of the Effect of a Low Glycemic Index Diet and Glycemic Load on Body Weight	N/A
Completed	`NCT02158130` - Effects of Aerobic Exercise Detraining	N/A
Completed	`NCT02188251` - A Study Investigating the Effects of Activamp on Body Weight, Fat Loss, and Metabolic Markers in Healthy Overweight Participants	Phase 2
Completed	`NCT02402985` - Comparison of a Plant Protein Diet to a Animal Protein Diet Emphasized in Type 2 Diabetics	N/A
Completed	`NCT01665339` - Preload, Weight Management, Risk of Cardiovascular Disease	Phase 3
Completed	`NCT01131871` - Innovative Approaches to Diet, Exercise and Activity	Phase 2
Completed	`NCT01170390` - Oral Contraceptives and Body Mass Index	Phase 4
Completed	`NCT02395835` - Methylation of the PPARg Promoter Region in Pregnancy	N/A
Completed	`NCT00814554` - Effectiveness Evaluation of Three Strategies of Promotion of Healthy Dietary and Physical Activity Behaviours to Prevent Weight Excess Among Teenagers	N/A
Completed	`NCT04901949` - The Course of Acute Pancreatitis in Patients With Different BMI Groups
Active, not recruiting	`NCT03843424` - Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers	N/A
Active, not recruiting	`NCT03575897` - Serial Assessment of Body Fat Accrual in Very Preterm Infants	N/A
Active, not recruiting	`NCT05601804` - TARGETing Healthy Weight Loss in the Context of Food Insecurity
Not yet recruiting	`NCT05004558` - Effects of Remote-based Resistance Training on Cardiometabolic Risk Factors, Cognitive Function, and Quality of Life in Adults Living With Alzheimer's Disease and/or Related Dementias	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.